US Patent Issued to JIANGSU HENGRUI PHARMACEUTICALS on Oct. 27 for "Anti-angiopoietin-like protein 3 (ANGPTL3) antibody and pharmaceutical composition thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,325, issued on Oct. 27, was assigned to JIANGSU HENGRUI PHARMACEUTICALS Co. LTD. (Lianyungang, China).

"Anti-angiopoietin-like protein 3 (ANGPTL3) antibody and pharmaceutical composition thereof" was invented by Yayuan Fu (Shanghai), Yingxia Xu (Shanghai), Bing Lin (Shanghai) and Weikang Tao (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an anti-angiopoietin-like protein 3(ANGPTL3) antibody and a use thereof. In particular, the present invention relates to the anti-ANGPTL3 antibody and an antigen-binding fragment thereof, or a pharmaceutically acceptable salt or solvent thereof, and a use thereof as a medic...